The Increasing Burden of Direct and Indirect Costs of IBD – Looking for Potential Solutions
The Lancet Gastroenterology & Hepatology has published a report on IBD, which examines the cost-effectiveness of treatments and provides recommendations for implementing more affordable strategies in the future. The report was presented at ECCO23 by Johan Burisch.